Fingolimod and risk of skin cancer among individuals with multiple sclerosis: a population-based cohort study protocol
Introduction Long-term population-based safety studies, applying advanced causal inference techniques, including an active comparator with new-user design, are needed to investigate skin cancer outcomes among individuals with multiple sclerosis (MS) treated with fingolimod. This study aims to descri...
Saved in:
| Main Authors: | Lisa Kuramoto, Larry D Lynd, Amir Khakban, Jacquelyn J Cragg, Anthony Traboulsee, Jiwon Oh, Analisa Jia, Weng Sut Sio, M A De Vera, Jonathan Loree, Roger Tam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/1/e088924.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
by: Trygve Holmøy, et al.
Published: (2018-01-01) -
Oral fingolimod to treat multiple sclerosis: see your cardiologist first
by: Douglas Kazutoshi Sato, et al.
Published: (2014-09-01) -
The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2014-09-01) -
Retrospective OCT Analysis of Sphingosine-1-Phosphate Modulator Fingolimod in Multiple Sclerosis
by: Wilson X. Wang, MD, MPhil, et al.
Published: (2025-11-01) -
Role of pattern and multifocal electroretinogram for macular evaluation in patients with multiple sclerosis treated with fingolimod
by: Randa H. Abdelgawad, et al.
Published: (2025-01-01)